Biology:Protochlamydia naegleriophila
Protochlamydia naegleriophila is an intracellular parasite of amoeba. This Protochlamydia species can be an etiological factor of pneumonia in humans when present in the amoeba P. naegleriophila, which lives in human lungs.[1]
Morphology
P. naegleriophila is a gram negative cocci, and is generally about 1 μm in diameter. The organism exists in three distinct morphological phases: elementary bodies, crescent bodies and reticulate bodies, which are associated with the phases of infection in amoeba. Elementary bodies generally have a smoother appearance and are smaller, whereas reticulate bodies are larger and have a rougher cell shape.[1]
Metabolism
The metabolism of this organism depends on its morphological phase. Elementary and crescent bodies are the spore-like state of the organism, and are metabolically inert. Reticulate bodies are the active, dividing phase of the organism, and are metabolically active.[1] When the organism is within an amoeba and is dividing, it is thought to use mainly the host ATP directly for energy, rather than through gaining ATP indirectly from the host through catabolism of host molecules. However, studies from the closely related Chlamydia trachomatis show that the organism is still capable of glycolysis.[2]
Genome
The strain "KNic" of P. naegleriophila, discussed in the article Protochlamydia naegleriophila as Etiologic Agent of Pneumonia from the journal emerging infectious diseases, has a genome size of 2.8 Mbp, a GC content of 43%, and about 2445 genes. The GenBank accession number for this strain is LN879502.[3]
Infection cycle
The first step of the infection cycle is when an elementary body enters the amoeba. P. naegleriophila will then transform into the metabolically active reticulate body, and begins to divide within the cell. Once there is a high enough density of Protochlamydia cells, the being to revert to elementary or crescent bodies. Then these elementary bodies will be released from the cell and begin a new cycle of infection.[1]
References
- ↑ 1.0 1.1 1.2 1.3 Casson, N., Michel, R., Müller, K.-D., Aubert, J. D., & Greub, G. (2008). Protochlamydia naegleriophila as Etiologic Agent of Pneumonia. Emerging Infectious Diseases, 14(1), 168–172.doi:10.3201/eid1401.070980
- ↑ Liang, P., Rosas-Lemus, M., Patel, D., Fang, X., Tuz, K., & Juárez, O. (2018). Dynamic energy dependency of Chlamydia trachomatis on host cell metabolism during intracellular growth: Role of sodium-based energetics in chlamydial ATP generation. The Journal of biological chemistry, 293(2), 510–522. doi:10.1074/jbc.M117.797209
- ↑ Bertelli, C., Cissé, O. H., Rusconi, B., Kebbi-Beghdadi, C., Croxatto, A., Goesmann, A., Collyn, F., & Greub, G. (2016). CRISPR System Acquisition and Evolution of an Obligate Intracellular Chlamydia-Related Bacterium. Genome biology and evolution, 8(8), 2376–2386. doi:10.1093/gbe/evw138
 |  |
